A Study of Rucaparib in Patients With Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ARIEL2)
Clinical trial NCT01891344 · COMPLETED
Trial details
- NCT number
- NCT01891344
- Sponsor
- pharmaand GmbH
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-30
- Primary completion
- 2019-11-05
- Enrollment
- 491
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.